Oral diclofenac combined with intra-portal pirarubicin: increased efficacy on liver VX2 tumour and hepatotoxicity in rabbits.

Donatini, B; Bognel, C; Munck, J N; Ramirez, L; Ardouin, P; Rougier, P

Donatini, B; Bognel, C; Munck, J N; Ramirez, L; Ardouin, P; Rougier, P.

Affiliation

Donatini B; Sandoz Clinical Development Centre, Camberley, Surrey, England.

J Cancer Res Clin Oncol ; 120(9): 529-32, 1994.

Article in En | MEDLINE | ID: mdl-8045918

Subject(s)

Diclofenac/administration & dosage; Doxorubicin/analogs & derivatives; Enprostil/pharmacology; Liver Neoplasms/drug therapy; Liver/drug effects; Administration, Oral; Animals; Antibiotics, Antineoplastic/administration & dosage; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin/administration & dosage; Enprostil/administration & dosage; Female; Portal System; Rabbits

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Doxorubicin / Diclofenac / Enprostil / Liver / Liver Neoplasms Limits: Animals Language: En Journal: J Cancer Res Clin Oncol Year: 1994 Type: Article Affiliation country: United kingdom

Search on Google

XML

PubMed Links